These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 28040716)

  • 21. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
    Caudell JJ; Gillison ML; Maghami E; Spencer S; Pfister DG; Adkins D; Birkeland AC; Brizel DM; Busse PM; Cmelak AJ; Colevas AD; Eisele DW; Galloway T; Geiger JL; Haddad RI; Hicks WL; Hitchcock YJ; Jimeno A; Leizman D; Mell LK; Mittal BB; Pinto HA; Rocco JW; Rodriguez CP; Savvides PS; Schwartz D; Shah JP; Sher D; St John M; Weber RS; Weinstein G; Worden F; Yang Bruce J; Yom SS; Zhen W; Burns JL; Darlow SD
    J Natl Compr Canc Netw; 2022 Mar; 20(3):224-234. PubMed ID: 35276673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.
    Bevers TB; Niell BL; Baker JL; Bennett DL; Bonaccio E; Camp MS; Chikarmane S; Conant EF; Eghtedari M; Flanagan MR; Hawley J; Helvie M; Hodgkiss L; Hoyt TL; Ivanovich J; Jochelson MS; Kulkarni S; Lancaster RB; Mauer C; Maxwell J; Patel BK; Pearlman M; Philpotts L; Plecha D; Plichta JK; Shakeri S; Smith ML; Streibert CL; Strigel RM; Tumyan L; Winkler NS; Wolverton DE; Bergman MA; Kumar R; Stehman K
    J Natl Compr Canc Netw; 2023 Sep; 21(9):900-909. PubMed ID: 37673117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
    Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Aoun P; Armand P; Bello CM; Benitez CM; Bierman PJ; Chen R; Dabaja B; Dean R; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hochberg EP; Huang J; Johnston PB; Kaminski MS; Kenkre VP; Khan N; Maddocks K; Maloney DG; Metzger M; Moore JO; Morgan D; Moskowitz CH; Mulroney C; Rabinovitch R; Seropian S; Tao R; Winter JN; Yahalom J; Burns JL; Ogba N
    J Natl Compr Canc Netw; 2018 Mar; 16(3):245-254. PubMed ID: 29523663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
    Meaney-Delman D; Bellcross CA
    Obstet Gynecol Clin North Am; 2013 Sep; 40(3):475-512. PubMed ID: 24021253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.
    Daly MB; Pilarski R; Axilbund JE; Buys SS; Crawford B; Friedman S; Garber JE; Horton C; Kaklamani V; Klein C; Kohlmann W; Kurian A; Litton J; Madlensky L; Marcom PK; Merajver SD; Offit K; Pal T; Pasche B; Reiser G; Shannon KM; Swisher E; Voian NC; Weitzel JN; Whelan A; Wiesner GL; Dwyer MA; Kumar R;
    J Natl Compr Canc Netw; 2014 Sep; 12(9):1326-38. PubMed ID: 25190698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multigene Testing for Hereditary Cancer: When, Why, and How.
    Offit K
    J Natl Compr Canc Netw; 2017 May; 15(5S):741-743. PubMed ID: 28515260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
    Randall LM; Pothuri B; Swisher EM; Diaz JP; Buchanan A; Witkop CT; Bethan Powell C; Smith EB; Robson ME; Boyd J; Coleman RL; Lu K
    Gynecol Oncol; 2017 Aug; 146(2):217-224. PubMed ID: 28596016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
    Eliade M; Skrzypski J; Baurand A; Jacquot C; Bertolone G; Loustalot C; Coutant C; Guy F; Fumoleau P; Duffourd Y; Arnould L; Delignette A; Padéano MM; Lepage C; Raichon-Patru G; Boudrant A; Bône-Lépinoy MC; Villing AL; Charpin A; Peignaux K; Chevrier S; Vegran F; Ghiringhelli F; Boidot R; Sevenet N; Lizard S; Faivre L
    Oncotarget; 2017 Jan; 8(2):1957-1971. PubMed ID: 27779110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.
    Weiss JM; Gupta S; Burke CA; Axell L; Chen LM; Chung DC; Clayback KM; Dallas S; Felder S; Gbolahan O; Giardiello FM; Grady W; Hall MJ; Hampel H; Hodan R; Idos G; Kanth P; Katona B; Lamps L; Llor X; Lynch PM; Markowitz AJ; Pirzadeh-Miller S; Samadder NJ; Shibata D; Swanson BJ; Szymaniak BM; Wiesner GL; Wolf A; Yurgelun MB; Zakhour M; Darlow SD; Dwyer MA; Campbell M
    J Natl Compr Canc Netw; 2021 Oct; 19(10):1122-1132. PubMed ID: 34666312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-risk patients with breast cancer may not receive genetic testing.
    Printz C
    Cancer; 2017 Jun; 123(11):1887. PubMed ID: 28542889
    [No Abstract]   [Full Text] [Related]  

  • 31. NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
    Horbinski C; Nabors LB; Portnow J; Baehring J; Bhatia A; Bloch O; Brem S; Butowski N; Cannon DM; Chao S; Chheda MG; Fabiano AJ; Forsyth P; Gigilio P; Hattangadi-Gluth J; Holdhoff M; Junck L; Kaley T; Merrell R; Mrugala MM; Nagpal S; Nedzi LA; Nevel K; Nghiemphu PL; Parney I; Patel TR; Peters K; Puduvalli VK; Rockhill J; Rusthoven C; Shonka N; Swinnen LJ; Weiss S; Wen PY; Willmarth NE; Bergman MA; Darlow S
    J Natl Compr Canc Netw; 2023 Jan; 21(1):12-20. PubMed ID: 36634606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.
    McDevitt T; Durkie M; Arnold N; Burghel GJ; Butler S; Claes KBM; Logan P; Robinson R; Sheils K; Wolstenholme N; Hanson H; Turnbull C; Hume S
    Eur J Hum Genet; 2024 May; 32(5):479-488. PubMed ID: 38443545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer.
    Szender JB; Kaur J; Clayback K; Hutton ML; Mikkelson J; Odunsi K; Dresbold C
    Int J Gynecol Cancer; 2018 Jan; 28(1):26-33. PubMed ID: 28930807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary breast and ovarian cancer syndrome: considering the complexities.
    Senter L
    Curr Probl Cancer; 2014; 38(6):226-34. PubMed ID: 25497409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
    Kinney AY; Howell R; Ruckman R; McDougall JA; Boyce TW; Vicuña B; Lee JH; Guest DD; Rycroft R; Valverde PA; Gallegos KM; Meisner A; Wiggins CL; Stroup A; Paddock LE; Walters ST
    Contemp Clin Trials; 2018 Oct; 73():123-135. PubMed ID: 30236776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome.
    Werner-Lin A; Ratner R; Hoskins LM; Lieber C
    J Genet Couns; 2015 Feb; 24(1):78-87. PubMed ID: 25011978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of Florida.
    Vadaparampil ST; Scherr CL; Cragun D; Malo TL; Pal T
    Clin Genet; 2015 May; 87(5):473-7. PubMed ID: 24735105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review.
    Williams CD; Bullard AJ; O'Leary M; Thomas R; Redding TS; Goldstein K
    J Racial Ethn Health Disparities; 2019 Jun; 6(3):570-583. PubMed ID: 30963508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.